Supplementary Table 1 Patient characteristics of patients with CGI according to occlusive CGI and NOMI
Observed n
CGI n=171 (39)
Occlusive CGI n=121 (71)
NOMI n=50 (29)
Age (years)# 121 67 (54-74) 63 (54-74) 60 (52-72)
Sex Male Female
121
47 (27) 124 (73)
25 (21) 96 (79)
22 (44) 28 (56) Postprandial pain
No pain
Pain, no hindrance in ADL Pain, small impairment ADL Pain, major impairment ADL Pain, complete impairment ADL Exercise-induced pain
No pain
Pain, no hindrance in ADL Pain, small impairment ADL Pain, major impairment ADL Pain, complete impairment ADL BMI (kg/m2)#
Weight loss
Weight loss (kg/month)# Diarrhea
Nausea
Duration of symptoms (months)#
119
112
116 119 83 112 119 118
33 (20) 29 (17) 55 (33) 32 (19) 19 (11)
39 (24) 20 (13) 58 (36) 28 (18) 15 (9) 21.5 (18.6-25.0)
126 (75) 1.8 (1.0-3.7)
39 (24) 66 (47) 12 (6.0-26.0)
22 (19) 18 (15) 47 (40) 24 (20) 8 (7)
27 (24) 14 (13) 40 (36) 23 (21) 8 (7) 22.2 (19.5-25.1)
88 (74) 1.6 (0.8-3.6)
26 (23) 45 (38) 12 (5.6-24.0)
11 (22) 11 (22) 8 (16) 8 (16) 11 (22)
12 (25) 6 (13) 18 (38)
5 (10) 7 (15) 22.5 (18.5-27.8)
38 (76) 1.9 (1.0-5.6)
13 (26) 21 (42) 12 (5.5-39.0) Cardiovascular disease
Hypertension DM type II
Hypercholesterolemia
121 121 121 121
93 (54) 108 (63)
29 (17) 80 (16)
56 (46) 79 (65) 20 (17) 58 (48)
28 (56) 29 (58) 9 (18) 22 (44) Family history CVD
Smoking
Smoking (pack years)# Alcohol
Alcohol (U/day)*
118 121 118 110 118
119 (71) 133 (78) 13 (2-26)
65 (42) 0 (0-10)
83 (70) 96 (79) 15 (3-28)
48 (44) 0 (0-2)
36 (72) 37 (74) 15 (0-31)
17 (38) 0 (0-2) Analgetics
None Opioids Non-opioids Antithrombotics None
Platelet aggregration inhibitors
121
121
134 (78) 26 (15)
11 (6)
66 (39) 82 (48)
95 (79) 19 (16) 7 (6)
46 (38) 58 (48)
39 (78) 7 (14)
4 (8)
20 (40) 24 (48)
1
Oral anticoagulants Both
20 (12) 3 (2)
16 (13) 1 (1)
4 (8) 2 (4) Values represent number and percentage (%) of patients.
Abbreviations: ADL, Activities of Daily Life; BMI, Body Max Index; DM, diabetes mellitus; CVD, cardiovascular disease.
#Median, interquartile range (IQR). *Median, range.
